Weiss M
Section of Pharmacokinetics, Department of Pharmacology, Martin Luther University Halle-Wittenberg, 06097 Halle, Germany.
Eur J Pharm Sci. 1999 Jan;7(2):119-27. doi: 10.1016/s0928-0987(98)00014-1.
Physiological pharmacokinetic models are based on the structure of the circulatory system reflecting the convective transport of drug by blood flow to the various organs and tissues. Distribution kinetics at the organ level is mostly simplified as transfer between well-stirred compartments neglecting a priori the effects of intravascular dispersion and diffusion within tissue parenchyma. Recirculatory models based on residence time theory overcome these structural limitations since they allow in a most general way the decomposition of the body into its natural subsystems. Because of the unidentifiability of the global multi-organ model on the basis of plasma concentration-time curves the following methods/experimental designs will be discussed which provide quantitative information regarding the subsystems under in vivo conditions: (i) determination of tissue concentration-time profiles (destructive sampling), (ii) estimation of the organ transit time density from input/output profiles and (iii) application of a recirculatory model with reduced complexity to clinical pharmacokinetic data.
生理药代动力学模型基于循环系统的结构,反映了药物通过血流对流输送到各个器官和组织的过程。器官水平的分布动力学大多被简化为在充分搅拌的隔室之间的转移,先验地忽略了血管内弥散和组织实质内扩散的影响。基于停留时间理论的再循环模型克服了这些结构限制,因为它们以最一般的方式允许将身体分解为其天然子系统。由于基于血浆浓度-时间曲线的全局多器官模型无法识别,因此将讨论以下方法/实验设计,这些方法/实验设计可提供体内条件下子系统的定量信息:(i) 组织浓度-时间曲线的测定(破坏性采样),(ii) 根据输入/输出曲线估计器官转运时间密度,以及 (iii) 将复杂度降低的再循环模型应用于临床药代动力学数据。